"Lansoprazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Descriptor ID |
D064747
|
| MeSH Number(s) |
D02.886.640.074.249 D03.383.725.024.249 D03.633.100.103.034.249
|
| Concept/Terms |
Lansoprazole- Lansoprazole
- Lansoprazol
- 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
- Lansoprazoles
|
Below are MeSH descriptors whose meaning is more general than "Lansoprazole".
Below are MeSH descriptors whose meaning is more specific than "Lansoprazole".
This graph shows the total number of publications written about "Lansoprazole" by people in this website by year, and whether "Lansoprazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lansoprazole" by people in Profiles.
-
Hypersensitivity to proton pump inhibitors: lansoprazole-induced Kounis syndrome. Int J Cardiol. 2009 May 29; 134(3):e94-6.
-
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. Aliment Pharmacol Ther. 2003 Oct 15; 18(8):829-36.